Supporting Patients by Family Education in Psychotic Illness: A Prospective Cohort Study

December 6, 2023 updated by: University of Alberta

Background: A lack of education, resources, and support for family carers of young adults with psychotic illnesses leaves them ill-equipped to support their loved one. Although family support groups exist, few groups offer evidence-based, skills-focused, psychoeducation taught by certified professionals and provided on a public-health level. By equipping families with skills and knowledge, public healthcare harnesses a powerful ally to maintain community stabilization.

Aims: The primary study goal is to implement a psychoeducation intervention for family carers supporting young adults with psychosis to reduce family burden and foster community stabilization of service users.

Methods: A longitudinal pre-post design will be used to assess the long-term effectiveness of the psychoeducation intervention for family carers supporting a young adult with psychosis on service utilization and functional indexes. Nine expert-reviewed, and family peer-informed psychoeducation modules are administered in 2-hour sessions over 9 weeks to family carers.

Conclusion: Presenting the novel approach of an expert-reviewed, peer-informed psychoeducation intervention for family carers, with a focus on knowledge and skill development, the researchers contribute to literature and best practice in patient and family-centered care.

Study Overview

Detailed Description

Background:

A lack of education, resources, and support for family carers of young adults with psychotic illnesses leaves them ill-equipped to support their loved one. Often family carers are excluded from the discharge planning process or are unaware of how to support of their loved one in community. Although best practice documents champion family involvement the implementation of these guidelines is challenge and families are often excluded from care.There is evidence of the disparity between best practice documents and true practice in the literature.

Family inclusion also addresses the impact of psychotic disease on the family's functioning and mental health. Psychotic illness (e.g., anosognosia, paranoia) can interfere with relational health and the natural maturation of family relationships over time. Families face extreme challenges when supporting a young adult with psychotic illness including social isolation, likely because their typical social supports are unable to relate to their situation, prompting them to seek support with those who share their situation (i.e., family support groups). Family carers, even in the face of these hardships, work with great tenacity toward improving service user stability in community.

There is a lack of high-quality effectiveness research showing longitudinal evidence for treatment effects on the carer and the young person in family psychoeducation groups. For example, one study provided a family intervention that was primarily knowledge- and support-based. These researchers used a pre-post design to assess the mental health knowledge, but did not assess long-term effectiveness of the group, overall family functioning, and functioning of the service user.

The intent for this longitudinal pre-post study is to evaluate the effect of skills-based educational programming for family carers supporting young adults admitted to or discharged from hospital with psychosis of any etiology on 6-month and 24-month service user readmission rates and service user/family functional indexes. The investigators hypothesize that system integration of a program which delivers early support for the family carers by way of an educational intervention beginning prior to or shortly after hospital discharge may reduce family burden as well as improve short- and long-term patient outcomes. To the investigators' knowledge, this study is the first to evaluate effectiveness of a family carer skills-based education intervention within a public healthcare system.

The investigators will use a longitudinal pretest-posttest design with a non-equivalent control group to evaluate the short- and long-term effectiveness of this family psychoeducation intervention. While a control group can be used for comparison of the service utilization data for young adults with psychosis using archival data from health records, gathering long-term control group data from families not participating in the trial is unethical in that denial of an intervention for up to two years is potentially harmful to both the families and the young adult they support. Likewise, control group data gathered directly from young adult service users presents the same ethical problem. Using archival health utilization data, however, allows us to exclude any service users' whose families have elected to access the psychoeducation program within the 2-year timeframe of the study. This allows us to find control data for health service utilization while not withholding the psychoeducation intervention from those who seek it. The investigators acknowledge that the control group is non-equivalent because families and service users who chose not to engage in the study may vary systematically from those who did.

Each measure will be taken pre-intervention (i.e., baseline), post-intervention, then again at 6- and 24-months post-intervention. A gift card incentive ($25.00 per data collection meeting) will be provided to family and young adult participants as a token of appreciation for their participation.

Service utilization data will be collected for 12-months pre-intervention to be compared to 12-months post-intervention and 12-24 months post-intervention.

Recruitment:

Study information will be disseminated by clinical teams and through community organizations, and family carers meeting eligibility criteria will self-identify for participation. Once recruited, and with family consent, young adult service users of participating family carers will be contacted for recruitment into the study.

Measures:

A variety of measures will be used to collect functional index data for the family members and the young adult service users. Health utilization data will be mined for 12-months pre-intervention, and up to 24-months post-intervention to assess long term service user outcomes. See Outcome Measures section for details.

Secondary Data Control Group:

While randomization into treatment and control groups was not feasible for this study, non-equivalent control group data can be mined from health records for young adults whose family did not participate in the study.

Intervention:

The educational modules are developed by experts in the areas of interest and are evidence based, family peer-informed and expert peer-reviewed. The curriculum consists of 9 modules delivered weekly over 9 weeks. Evidence-based content includes the Listen-Empathize-Agree-Partner (LEAP) communication Program, and Acceptance and Commitment Therapy. The family psychoeducation classes are to take place at a designated AHS location.

Limitations and Conclusion:

The described protocol is one of the first attempts in the literature to evaluate an evidence-based intervention for carers of young adults with psychotic illness. The current study builds on others by incorporating psychoeducational elements, modules specific to the LEAP approach, and modules specific to ACT. Furthermore, the design of the study intends to gather longitudinal 24-month post-intervention data from carers and service users, including health service utilization data.

Several limitations must be considered with regards to this protocol. First, using a pre-post design the investigators cannot draw causal conclusions regarding the effect of the intervention. To address this limitation the investigators will use secondary data from health records as a non-equivalent control group for health utilization data. A second limitation is that participants self-select for the study, and may differ systematically from those who choose not to participate. For example, the sample will likely be biased towards families who are already supportive and involved in their young adults' care. The sample of young adults participating will be additionally biased because those who are especially unwell may be unable to participate. By comparing the health utilization data of the participants to the nonequivalent control group in a longitudinal design the investigators will gain some evidence to rule out history effects. Even with these limitations, the described design builds on existing knowledge of effective family psychoeducation groups and their long term effects on young adults experiencing psychosis.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Alberta
      • Edmonton, Alberta, Canada, T6G 2B7
        • Recruiting
        • University of Alberta Hospital
        • Contact:
      • Edmonton, Alberta, Canada, T5H 3V9
        • Recruiting
        • Royal Alexandra Hospital
        • Contact:
      • Edmonton, Alberta, Canada, T6L 5X8
        • Recruiting
        • Grey Nuns Community Hospital
        • Contact:
      • Edmonton, Alberta, Canada, T5J 2J7
        • Recruiting
        • Alberta Hospital Edmonton
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

17 years to 27 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Young adult service user is aged 17-27 at time of recruitment
  • Young adult service user has had an admission or discharge from an Alberta Health Services or Covenant Health psychiatric unit for psychosis in the Edmonton Zone within previous 12-months

Exclusion Criteria:

  • Not proficient in English
  • Young adult service user has NOT had an admission or discharge from an Alberta Health Services or Covenant Health psychiatric unit for psychosis in the Edmonton Zone within previous 12-months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Family Psychoeducation Intervention Arm
These participants will receive the psychoeducation intervention and outcome measures will be taken from them and their young adult service user. The intervention includes psychoeducation on stages of a family's journey, the biopsychosocial basis of psychosis, and skills for coping (Acceptance and Commitment Therapy for Caregivers) and communicating (LEAP).
Psychoeducation for families supporting young adults with psychosis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Family Burden Interview Schedule
Time Frame: Baseline-Day 0 (Pre-intervention)
assesses overall burden of the family related to supporting a loved one with addiction and mental health concerns, including the following domains: financial, routines and activities, leisure, relationships, physical health, mental health
Baseline-Day 0 (Pre-intervention)
Family Burden Interview Schedule
Time Frame: 9-Week Follow-Up (Post-Intervention)
assesses overall burden of the family related to supporting a loved one with addiction and mental health concerns, including the following domains: financial, routines and activities, leisure, relationships, physical health, mental health
9-Week Follow-Up (Post-Intervention)
Family Burden Interview Schedule
Time Frame: 6-Month Follow-Up (Post-Intervention)
assesses overall burden of the family related to supporting a loved one with addiction and mental health concerns, including the following domains: financial, routines and activities, leisure, relationships, physical health, mental health
6-Month Follow-Up (Post-Intervention)
Family Burden Interview Schedule
Time Frame: 24-Month Follow-Up (Post-Intervention)
assesses overall burden of the family related to supporting a loved one with addiction and mental health concerns, including the following domains: financial, routines and activities, leisure, relationships, physical health, mental health
24-Month Follow-Up (Post-Intervention)
Positive and Negative Symptom Schedule
Time Frame: Baseline-Day 0 (Pre-intervention)
assesses overall symptom severity of service users, including 7 positive symptoms (e.g., hallucinations, grandiosity, etc.), 7 negative symptoms (e.g., blunted affect, emotional withdrawal) and general symptoms (e.g., anxiety, lack of judgement/insight, poor impulse control)
Baseline-Day 0 (Pre-intervention)
Positive and Negative Symptom Schedule
Time Frame: 9-Week Follow-Up (Post-Intervention)
assesses overall symptom severity of service users, including 7 positive symptoms (e.g., hallucinations, grandiosity, etc.), 7 negative symptoms (e.g., blunted affect, emotional withdrawal) and general symptoms (e.g., anxiety, lack of judgement/insight, poor impulse control)
9-Week Follow-Up (Post-Intervention)
Positive and Negative Symptom Schedule
Time Frame: 6-Month Follow-Up (Post-Intervention)
assesses overall symptom severity of service users, including 7 positive symptoms (e.g., hallucinations, grandiosity, etc.), 7 negative symptoms (e.g., blunted affect, emotional withdrawal) and general symptoms (e.g., anxiety, lack of judgement/insight, poor impulse control)
6-Month Follow-Up (Post-Intervention)
Positive and Negative Symptom Schedule
Time Frame: 24-Month Follow-Up (Post-Intervention)
assesses overall symptom severity of service users, including 7 positive symptoms (e.g., hallucinations, grandiosity, etc.), 7 negative symptoms (e.g., blunted affect, emotional withdrawal) and general symptoms (e.g., anxiety, lack of judgement/insight, poor impulse control)
24-Month Follow-Up (Post-Intervention)
Manchester Short Assessment of Quality of Life
Time Frame: Baseline-Day 0 (Pre-intervention)
assessing service user quality of life on a scale of 1 (couldn't be worse) to 7 (couldn't be better) and "yes/no" for select items.
Baseline-Day 0 (Pre-intervention)
Manchester Short Assessment of Quality of Life
Time Frame: 9-Week Follow-Up (Post-Intervention)
assessing service user quality of life on a scale of 1 (couldn't be worse) to 7 (couldn't be better) and "yes/no" for select items.
9-Week Follow-Up (Post-Intervention)
Manchester Short Assessment of Quality of Life
Time Frame: 6-Month Follow-Up (Post-Intervention)
assessing service user quality of life on a scale of 1 (couldn't be worse) to 7 (couldn't be better) and "yes/no" for select items.
6-Month Follow-Up (Post-Intervention)
Manchester Short Assessment of Quality of Life
Time Frame: 24-Month Follow-Up (Post-Intervention)
assessing service user quality of life on a scale of 1 (couldn't be worse) to 7 (couldn't be better) and "yes/no" for select items.
24-Month Follow-Up (Post-Intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Inpatient Readmission Rate
Time Frame: 12-months pre-intervention
Readmission rate for mental health diagnosis within 30 days of an inpatient discharge
12-months pre-intervention
Inpatient Readmission Rate
Time Frame: 12-months post-intervention
Readmission rate for mental health diagnosis within 30 days of an inpatient discharge
12-months post-intervention
Inpatient Readmission Rate
Time Frame: 12-24 months post-intervention
Readmission rate for mental health diagnosis within 30 days of an inpatient discharge
12-24 months post-intervention
Inpatient Admission Frequency
Time Frame: 12-months pre-intervention
Frequency of hospital admissions for mental health diagnosis
12-months pre-intervention
Inpatient Admission Frequency
Time Frame: 12-months post-intervention
Frequency of hospital admissions for mental health diagnosis
12-months post-intervention
Inpatient Admission Frequency
Time Frame: 12-24 months post-intervention
Frequency of hospital admissions for mental health diagnosis
12-24 months post-intervention
Emergency Department Visit Frequency
Time Frame: 12-months pre-intervention
Frequency of emergency departments visits within 30 days of last emergency presentation
12-months pre-intervention
Emergency Department Visit Frequency
Time Frame: 12-months post-intervention
Frequency of emergency departments visits within 30 days of last emergency presentation
12-months post-intervention
Emergency Department Visit Frequency
Time Frame: 12-24 months post-intervention
Frequency of emergency departments visits within 30 days of last emergency presentation
12-24 months post-intervention
Community Appointment Frequency
Time Frame: 12-months pre-intervention
Appointment frequency for community-based services
12-months pre-intervention
Community Appointment Frequency
Time Frame: 12-months post-intervention
Appointment frequency for community-based services
12-months post-intervention
Community Appointment Frequency
Time Frame: 12-24 months post-intervention
Appointment frequency for community-based services
12-24 months post-intervention
Crisis Service Frequency
Time Frame: 12-months pre-intervention
Frequency of crisis calls and visits
12-months pre-intervention
Crisis Service Frequency
Time Frame: 12-months post-intervention
Frequency of crisis calls and visits
12-months post-intervention
Crisis Service Frequency
Time Frame: 12-24 months post-intervention
Frequency of crisis calls and visits
12-24 months post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Melanie Robles, md, University of Alberta
  • Principal Investigator: Adam Abba-Aji, MD, Alberta Health services

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2022

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

September 1, 2025

Study Registration Dates

First Submitted

August 9, 2022

First Submitted That Met QC Criteria

August 11, 2022

First Posted (Actual)

August 12, 2022

Study Record Updates

Last Update Posted (Actual)

December 8, 2023

Last Update Submitted That Met QC Criteria

December 6, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD datasets that will be collected and analyzed for this study will be available by request from the corresponding author. Given the small study population, narrow geographic region of recruitment, and Alberta Health Services' data sharing policies, potentially identifying demographic data will not be available.

IPD Sharing Time Frame

Data will be made available to requesting individuals/organizations through the corresponding author for a timeframe appropriate to the requesting party's needs.

IPD Sharing Access Criteria

The purpose and timeframe of the requesting individuals/organizations dataset access will be reviewed on a case by case basis by the research team and is subject to approval by Alberta Health Services based on data sharing policies.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychotic Disorders

Clinical Trials on Supporting Patients by Family Education in Psychotic Illness Group

3
Subscribe